Expanded Access for Relatlimab

Status

NO_LONGER_AVAILABLE

Phases

Unknown

Study type

Expanded Access

Source

ClinicalTrials.gov

Registry ID

NCT05170659

Enrollment

Unknown

Registered

2021-12-28

Start date

Unknown

Completion date

Unknown

Last updated

2022-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

This is an expanded access designed to provide access to Relatlimab for eligible participants.

DRUGRelatlimab

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026